Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and effectiveness of retrograde intrarenal surgery versus percutaneous nephrolithotomy in older patients: a systematic review and meta-analysis by the EAU-YAU urolithiasis and EAU endourology sections.

BMC geriatrics·2026
Same author

Predicting the Development of BCG-unresponsive Disease Among Patients with High-grade Non-muscle-invasive Bladder Cancer: An International Multicenter Analysis.

European urology oncology·2026
Same author

Polymorphisms in immune checkpoint genes might influence bladder cancer risk and clinical outcome.

Human immunology·2026
Same author

Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomes.

World journal of urology·2026
Same author

Multi-institutional external validation of the European risk classification for high-grade Ta non-muscle-invasive bladder cancer.

World journal of urology·2026
Same author

The Impact of II-look Ureteroscopy on Survival in Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study of EAU-YAU Urothelial Working Group.

European urology open science·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
Same journal

Neoadjuvant Immunotherapy-Based Treatment Versus Chemotherapy Alone in Resectable Locally Advanced dMMR/MSI-H Gastric Cancer: A Real-World Study with Meta-Analysis.

Cancers·2026
See all related articles

Related Experiment Video

Updated: Jul 30, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.6K

Sentinel Lymph Node Techniques in Urologic Oncology: Current Knowledge and Application.

Bartosz Małkiewicz1, Paweł Kiełb1, Maximilian Kobylański1

  • 1University Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland.

Cancers
|May 13, 2023
PubMed
Summary
This summary is machine-generated.

Sentinel lymph node (SLN) biopsy is an experimental technique for staging urological malignancies. While promising for detecting cancer spread, further research is needed to improve its accuracy and application in prostate, bladder, and kidney cancers.

Keywords:
lymphadenectomymetastasessentinel lymph node biopsysentinel lymph node dissectionurological malignancies

More Related Videos

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

19.7K
Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

23.3K

Related Experiment Videos

Last Updated: Jul 30, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.6K
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

19.7K
Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

23.3K

Area of Science:

  • Urologic Oncology
  • Surgical Oncology
  • Diagnostic Imaging

Background:

  • Lymph node (LN) metastases significantly worsen prognosis in urological cancers.
  • Current imaging lacks sensitivity for micrometastases, necessitating broad lymph node dissection (LND).
  • Existing LND templates are suboptimal, risking under- or over-staging.

Purpose of the Study:

  • To review the current knowledge and future potential of sentinel lymph node (SLN) biopsy in urological malignancies.
  • To discuss the challenges and advancements in SLN techniques for prostate, bladder, and kidney cancers.

Main Methods:

  • Review of existing literature on SLN biopsy in urologic oncology.
  • Analysis of current limitations and potential improvements in tracers, imaging, and surgical approaches.

Main Results:

  • SLN biopsy is established in other cancers but remains experimental in urologic oncology.
  • High false-negative rates and limited data hinder its widespread adoption in prostate, bladder, and kidney cancers.
  • Advancements in technology may enhance SLN procedure efficacy.

Conclusions:

  • Sentinel lymph node biopsy holds potential for accurate staging in urological malignancies.
  • Further research and technological development are crucial for optimizing SLN techniques in urologic oncology.